Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2018

01-08-2018 | Capsule Commentary

Capsule Commentary on Lin et. al. Empirical Comparison of Publication Bias Tests in Meta-analysis

Author: Akira Kuriyama, MD, MPH

Published in: Journal of General Internal Medicine | Issue 8/2018

Login to get access

Excerpt

Studies with statistically significant findings are more likely to be published than those with non-significant findings. This publication bias is a threat to consumers of meta-analyses, because it can exaggerate the evidence supporting treatment and hence mislead decision-making. Some statistical tests have been developed in an attempt to detect and adjust for this bias. …
Literature
1.
2.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006; 295(6):676–80.CrossRefPubMed
3.
Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332.CrossRefPubMedPubMedCentral
4.
Kuriyama A, Takahashi N, Nakayama T. Reporting of critical care trial abstracts: a comparison before and after the announcement of CONSORT guideline for abstracts. Trials 2017; 18(1):32.CrossRefPubMedPubMedCentral
Metadata
Title
Capsule Commentary on Lin et. al. Empirical Comparison of Publication Bias Tests in Meta-analysis
Author
Akira Kuriyama, MD, MPH
Publication date
01-08-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4528-1

Other articles of this Issue 8/2018

Journal of General Internal Medicine 8/2018 Go to the issue

Original Research

Empirical Comparison of Publication Bias Tests in Meta-Analysis

Letter to the Editor

Design and Interpretation of Noninferiority Trials

Original Research

The Association Between Provider Price and Complication Rates for Outpatient Surgical Services

Original Research

The American Board of Internal Medicine Maintenance of Certification Examination and State Medical Board Disciplinary Actions: a Population Cohort Study

Original Research

Prevalence and Correlates of Disordered Eating Behaviors Among Young Adults with Overweight or Obesity

Original Research

Estimated Impact of US Preventive Services Task Force Recommendations on Use and Cost of Statins for Cardiovascular Disease Prevention
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits